Recurrent Myocardial Infarctions Due to Thrombosis of a Coronary Aneurysm in Neurofibromatosis Type 1: Is Antiplatelet Treatment Enough?

JACC Cardiovasc Interv. 2015 Apr 20;8(4):e55-7. doi: 10.1016/j.jcin.2014.10.031. Epub 2015 Mar 26.

Authors

Javier Molina-Martin de Nicolas¹, Alfonso Jurado Roman², Belen Rubio Alonso², Julio Garcia Tejada²

Affiliations

¹ Cardiology Department, University Hospital Doce de Octubre, Madrid, Spain. Electronic address: javier.molina.mdn@gmail.com.
² Cardiology Department, University Hospital Doce de Octubre, Madrid, Spain.

PMID: 25819181
DOI: 10.1016/j.jcin.2014.10.031

No abstract available

Keywords: anticoagulation; coronary aneurysm; myocardial infarction; neurofibromatosis type 1.

Publication types

Case Reports

MeSH terms

Aged
Anterior Wall Myocardial Infarction / complications
Anterior Wall Myocardial Infarction / diagnosis*
Anterior Wall Myocardial Infarction / drug therapy
Coronary Aneurysm / complications
Coronary Aneurysm / diagnostic imaging*
Coronary Aneurysm / therapy
Coronary Angiography / methods
Coronary Thrombosis / complications
Coronary Thrombosis / diagnostic imaging
Coronary Thrombosis / drug therapy*
Drug Therapy, Combination
Electrocardiography / methods
Female
Follow-Up Studies
Humans
Neurofibromatosis 1 / complications
Neurofibromatosis 1 / diagnosis*
Neurofibromatosis 1 / therapy
Platelet Aggregation Inhibitors / therapeutic use*
Recurrence
Risk Assessment
Severity of Illness Index
Treatment Outcome

Substances

Platelet Aggregation Inhibitors